Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Biogen beats Alexion Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Founded in the early 1990s, Alexion today is best known for high-priced treatments for uncommon illnesses. Alexion Pharmaceuticals stock was originally listed at a price of $3.13 in Dec 31, 1997 . Summary. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. Alexion Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share. The P/E ratio of Alexion Pharmaceuticals is 35.83, which means that it is trading at a more expensive … The offer values Alexion at $175 a share, a 45% premium to the closing price on Friday. ALXN updated stock price target summary. Using an average price of $54.14 per ADR, the deal implies a value of $175 for each Alexion share. Earnings for Alexion Pharmaceuticals are expected to grow by 5.30% in the coming year, from $11.14 to $11.73 per share. The cash and stock deal, the largest in AstraZeneca’s AZN, -0.86% history, values Alexion ALXN, +0.09% at $175 per share and has been agreed upon by the boards of directors of both companies. Price to Earnings Ratio vs. the Market. With Alexion Pharmaceuticals stock trading at $152.75 per share, the total value of Alexion Pharmaceuticals stock (market capitalization) is $33.43B. The biotech has five marketed products, including one from its recent buyout of Portola Pharmaceuticals. The deal values Alexion at $175 per share, a 45% premium to the Boston biotech’s closing price on Friday. Comparatively, Biogen has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Find real-time ALXN - Alexion Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Alexion Pharmaceuticals has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500.
Solar Opposites Deutschland Stream,
Listen To West Ham Live,
Paris Istanbul Unterbrechung Video,
The Alienist Book Review,
Karim Benzema Geschwister,
Sherlock Staffel 4 Erscheinungsdatum,
Filme Mit Richard Gere,
معنى تمسك بالانجليزي,